Testing effectiveness (Phase 2)Looking for participantsNCT07220720What this trial is testingPOSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 LesionsWho this might be right forProstate University of Florida 30
Not applicableLooking for participantsNCT06867588What this trial is testingThe Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA)Who this might be right forMultiparametric MRILesion PI-RADS 3 Jules Bordet Institute 68
Not applicableStudy completedNCT06029088What this trial is testingRisk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate CancerWho this might be right forProstate CancerProstate Adenocarcinoma Ankara Etlik City Hospital 616
Not applicableStudy completedNCT06116344What this trial is testingImproving Prostate Lesion Classification and Development of a PI-RADS 3 ClassifierWho this might be right forProstate Cancer Paracelsus Medical University 173
Not applicableUnknownNCT04573179What this trial is testingEffectiveness of 68Ga-PSMA PET/MRI for Improving the Detection of csPCa in Lesions With PI-RADS Score 3Who this might be right forProstatic Neoplasms The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 60